Purpose To determine the efficacy of real-time PCR for the diagnosis and prognosis of varicella-zoster virus (VZV) keratitis. Study design Retrospective case series. Methods Patients: 545 consecutive patients with keratitis were examined to quantify copy numbers of VZV DNA by realtime PCR. Association of copy numbers of VZV DNA to clinical signs and disease course was assessed by logistic regression analysis and Cox proportional hazard model. Results Of the 545 eyes, 38 (6.9%) were diagnosed as VZV keratitis. The median copy number of the VZV DNA was 10 4.19 copies; this number was significantly associated with diagnosis of VZV keratitis with the highest odds ratio of 3390 (for median copy) compared to the clinical signs. The diagnostic accuracy of the VZV DNA copy indicated good diagnostic value of area under the curve (0.92) by receiver operating characteristic analysis, and detection of unrelated VZV DNA from the cornea was very rare (0.2%). When the VZV DNA copy and clinical signs were assessed for association with the disease course of herpes zoster ophthalmicus, the disease duration was significantly prolonged in VZV keratitis cases with higher numbers of VZV DNA copies, iritis, and history of recurrences. The amount of VZV DNA led to a continuous risk of prolonged disease duration until the ocular inflammation subsided (hazard ratio 0.17, 95% CI 0.07-0.42, for median copies). Conclusions Higher VZV DNA copy numbers are associated with the refractoriness of VZV keratitis, and its evaluation may be a useful way to clinically diagnose and manage VZV keratitis.
Introduction
Herpes zoster contributes significantly to morbidity in elderly individuals and is mainly caused by a reactivation of the varicella-zoster virus (VZV). Almost one-third of individuals are estimated to be affected by herpes zoster [1, 2] , and up to 20% of herpes zoster infections are expressed as herpes zoster ophthalmicus (HZO) [2, 3] . Patients with HZO have significantly higher risks of stroke and post-herpetic neuralgia [4] [5] [6] . Importantly, ocular complications are observed in 35.1-65% of HZO patients [7, 8] .
In spite of its widespread occurrence, the etiology of the ocular complications associated with HZO has not been determined. For example, the DNA of VZV in the ocular lesions of VZV keratitis remains occasionally undetected by conventional PCR [9] . For VZV keratitis cases positive for VZV DNA after HZO, the DNA of VZV is believed to disappear soon after the onset. Thus, it is still unclear whether active keratitis lesions are caused by VZV replication or as an inflammatory response by the host.
The purpose of this study was to determine the relationship between the presence of VZV DNA in the eye and the diagnosis of HZO. To accomplish this, we quantified the VZV DNA by quantitative real-time PCR (qPCR) and assessed the association of the copy numbers with the clinical signs with and without previous HZO. We then analyzed the course of ocular complications after HZO. We managed to show that VZV DNA was a significant risk factor for prolonged ocular complications after HZO.
Materials and methods

Patients eligibility and diagnostic criteria of VZV keratitis
The medical records of 545 consecutive cases with clinically diagnosed keratitis were reviewed, and all were examined at the Tottori University Medical Hospital between November 2005 and September 2016. All of these cases had undergone qPCR to try to determine whether VZV was the cause of the ocular infection. Of these 545 cases, 283 patients were men, and the mean age was 56.1 ± 23.1 years. The diagnosis of HZO was based on the presence of primary skin rashes with erythema within the ophthalmic dermatome as described in detail [9] . The diagnosis of VZV keratitis included acute, chronic, and recurrent VZV keratitis. Acute VZV keratitis was diagnosed when keratitis either with or without epithelial lesions was present with preceding skin rashes < 90 days following the onset of skin lesions [2] . In cases without preceding skin rashes with positive VZV detected by conventional PCR in ocular specimens, a diagnosis of acute VZV keratitis was made by the responsiveness to oral valaciclovir/acyclovir or topical acyclovir ointment, or the combination of these anti-herpetic drugs and steroid treatment. Chronic VZV keratitis was defined as present when the activity required anti-viral drugs or steroids for ≥ 90 days from the onset of skin lesions [2] . Recurrent disease was defined as present when keratitis recurred ≥ 90 days after the resolution of the signs without the use of anti-viral drugs or steroids. DNA samples were collected at each outpatient visit until the clinical symptoms for the VZV keratitis were resolved.
A diagnosis of herpes simplex keratitis was made when herpes simplex virus (HSV) was detected in ocular specimens by PCR. A diagnosis of any other non-VZV keratitis, including bacterial keratitis, fungal keratitis, acanthamoeba keratitis, adenoviral keratitis, or autoimmune keratitis, was made by conventional culturing, smearing, and PCR as described [10] [11] [12] [13] .
This study was approved by the Institutional Review Board of the Faculty of Medicine, Tottori University, Tottori, Japan. Informed consent was obtained prior to the procedures from all of the participants after an explanation of the procedures to be used.
Quantitative real-time PCR
Samples were collected from the ocular surface and cornea by rinsing them with 400 μl of saline solution without touching the eyelids and skin lesions. DNA was extracted from the samples with the QIAamp DNA mini kit (Qiagen) and was amplified with the LightCycler (Roche) using QuantiTect Probe PCR kit (Qiagen) and primers (Supplementary Table 1 ) [14, 15] . To determine the copy numbers of the VZV DNA, a standard curve was generated with serial dilutions of synthesized DNA fragments of the VZV polymerase gene [14] . The limit of detection at a 95% detection probability was 49 copies/assay. The VZV copy number was adjusted by measuring the human GAPDH copy [15] .
Statistical analyses
Data are presented as the means ± standard deviations. For bilateral cases, the more severely affected eye was used for statistical analyses. Multivariate logistic regression analysis was used to compute the odds ratio (OR) of the VZV copy number (per median) for clinical signs. Clinical signs, including periocular skin rash, iritis (with mutton fat keratic precipitates), ocular hypertension, corneal dendritic lesions, and scleritis, were analyzed as dichotomic variable (present or absent). The area under the curve (AUC) was calculated using the receiver operating characteristic (ROC) analysis. Spearman correlation analysis was performed to determine the association of VZV copy number at the first visit and duration of the disease. The duration of the disease was defined as time from onset of HZO to the resolution of ocular signs without topical medications (anti-virals or steroids). For recurrent cases without immediate preceding skin rashes, the disease duration was calculated from the onset of the ocular signs. Kaplan-Meier survival analysis was used to determine the association of disease duration with the clinical signs or VZV DNA copy numbers. Cox proportional hazard model with shared frailty was used to calculate the hazard ratio (HR) during the course of the disease. Statistical analyses were conducted using Stata 14. A P < 0.05 was considered significant.
Results
Diagnostic efficacy of qPCR for VZV DNA
Patients with corneal ulcer or inflammatory keratitis suspected as caused by VZV infection or requiring the exclusion of VZV for diagnosis were studied. Of the 545 eyes, 38 (6.9%) were diagnosed with VZV keratitis. Thirty-seven eyes had HZO keratitis and 1 eye had varicella keratitis developed after varicella in a 2-year-old patient. The mean age of the HZO keratitis patients was 63.2 ± 20.0 years ( Table 1) .
The qPCR was positive for VZV DNA in 32 eyes (5.9%); 30 eyes of these positive cases had HZO keratitis and one eye had varicella keratitis. All the VZV keratitis cases had prior periocular skin rashes, and 35 eyes (92.1%) were within 3 months of the initial visit. The percentage of eyes with ocular shedding of VZV DNA by non-VZV infection was very low in the diseased corneas (0.2%).
For the eyes diagnosed with VZV keratitis, the mean copy number was 10 4.21 ± 10 2.61 , and the median copy number was 10 4.19 . VZV DNA was significantly associated with VZV keratitis (OR 3390 for 10 4.19 (median) copies, 6.9/log copy, after age and GAPDH adjustments, P = 0.000; logistic analysis, Table 2 ). Periocular skin rashes (irrespective of dermatomal distribution and within the prior 3 months) were also significantly associated with VZV keratitis, and their incidence was followed by ocular hypertension, iritis with mutton fat keratic precipitates, dendritic lesions, and scleritis (Table 2) .
Next, we determined how these clinical signs and VZV DNA copy numbers were related to the diagnosis of VZV keratitis (Table 2 ). VZV DNA qPCR had a sensitivity of 81.6% and specificity of 99.8%. The likelihood ratio, which denotes the efficiency of the test, was the highest at 408 (Table 2 ). In contrast to the clinical signs, qPCR for VZV DNA had higher positive predictive value and likelihood ratio, indicating that qPCR is accurate for both the negative and positive results for the diagnosis of VZV keratitis.
Of the 545 eyes, periocular skin rashes were observed in 49 eyes (9.0%), and 15 of these eyes (30.6%) were not related to VZV infection. The sensitivity and specificity of the skin rashes was 92.1 and 97.2%, and its likelihood ratio was lower at 32.9.
Other clinical signs, including ocular hypertension, iritis, corneal dendritic lesions, and scleritis, were also significantly associated with VZV keratitis, but were lower in positive predictive value and likelihood ratio.
Next, we used receiver operating characteristic analysis (ROC; Fig. 1 ) to assess the diagnostic accuracy of these signs in comparison with qPCR. The AUC for periocular skin rashes calculated as reference was 0.95 (95% CI 0.90-0.99). The AUC for VZV qPCR was 0.92 (95% CI 0.86-0.98) after GAPDH adjustments and was not significantly different for the skin rashes. The AUCs for dendritic lesions, ocular hypertension, and iritis were 0.66 (95% CI 0.58-0.74), 0.62 (95% CI 0.55-0.70), and 0.60 (95% CI 0.53-0.67) respectively, and their diagnostic accuracy was significantly lower than that of qPCR (P = 0.000). 
Association of copy numbers of VZV DNA to clinical signs and disease course
Using logistic regression analysis we determined whether the copy numbers of the VZV DNA were significantly associated with the clinical signs or outcomes ( Table 3) . As expected, the copy number of DNA at the first visit was significantly associated with the presence of periocular skin rashes (OR 100.6 for median copies, 95% CI 22.9-441.9, P = 0.000, age and GAPDH adjusted). Notably, the copy number of DNA was significantly associated with iritis with OR of 6.0 indicating that a high VZV copy number was especially associated with intraocular inflammation. This was followed by ocular hypertension (OR 3.7) and dendritic lesion (OR 3.5).
We determined whether the amount of the VZV DNA at the initial diagnosis of keratitis can predict the refractoriness and prognosis of HZO keratitis (excluding varicella keratitis). A higher copy number of VZV DNA at the first visit was significantly correlated with the duration of the disease (ρ = 0.53, P = 0.0007, Spearman correlation analysis). In refractory cases with iritis as the intraocular inflammation, the VZV genome was detected until all clinical signs of the keratitis were not detected (Fig. 2) .
When the history of recurrences in HZO keratitis patients was evaluated, 8 eyes (21.6%) had a history of recurrence. Of these 8 eyes, 2 (25%) were from immune compromised patients, who had significantly higher number of recurrences with a 50.6% increase of chance (P = 0.019 after VZV DNA copy adjustment). The sensitivity and specificity of VZV qPCR and clinical signs to diagnose VZV keratitis are plotted to determine the AUC as diagnostic accuracy by receiver operating characteristic analysis. The VZV DNA copy number has a very high accuracy and is comparable to that for skin rashes calculated as reference and is significantly better than the other signs The mean duration of the HZO keratitis was 119 days (95% CI 82-155). Kaplan-Meier survival analyses were performed to determine whether high copy numbers (more than the median) at the first visit, the clinical characteristics and previous recurrences were associated with the disease duration. The results showed that high VZV copy numbers (≥ median; P = 0.008, log-rank test), iritis (P = 0.01), and history of recurrences were significantly associated with the duration of the disease (P = 0.006, Fig. 3) . Importantly, iritis with high VZV copy number had the most significant effect on the disease duration.
During the course of the disease process, we monitored the copy numbers of the VZV DNA until the HZO keratitis resolved. VZV DNA was continuously detected during outpatient visits with a declining tendency and became undetectable when signs become absent. We then calculated the HR of VZV copy numbers during the course (including the first visit) of the disease duration. VZV copy numbers indicated highly significant HR (0.17 per median of VZV copies, 95% CI 0.07-0.42, P = 0.000). Thus, there was a direct link between the disease course and the VZV copy numbers. Whenever a VZV copy number was present, a prolonged disease course could be predicted, as the copy number declined the disease course became shorter until, when the copy number could not be detected any more, it became negligible. HR indicated that the keratitis was predicted to remain six times longer on the day when the VZV copy numbers exceeded the median. The presence of iritis was also a significant risk factor associated with longer disease duration with comparable HR (HR, 0.14, 95% CI 0.04-0.49, P = 0.002). When the history of recurrences was assessed, the HR was calculated to be 0.15 (95% CI 0.03-0.69, P = 0.01), indicating that recurrences were also associated significantly with a prolonged disease duration.
Discussion
Our results show that qPCR is highly effective in diagnosing ocular VZV infections. qPCR showed two important findings. First, in cases of high viral loads on the ocular surface after HZO, the prolongation of keratitis was significantly associated with continuous viral presence. Second, VZV keratitis was strictly associated with previous HZO although VZV iritis without keratitis can often occur without any noticeable history of HZO. This is important for the management of refractory ocular complications after HZO because ocular inflammations were previously believed to be an anti-viral immune response without viral presence and therefore not treated with antiviral medications.
Zaal et al. used conventional PCR to examine the inflammation of VZV keratitis after HZO [9] . Because the inflammation often persisted after the VZV genome became undetectable, they suggest that inflammation was an important component of the pathology of VZV keratitis.
Considering the inflammatory aspect of ocular complications after HZO, a combination of antiviral drugs and steroids is generally used, although a consensus has not been reached on how antiviral agents should be used [16] . The general belief is that the period of VZV replication in the lesion does not exceed the acute phase of skin lesions. Currently, one-third of corneal specialists use antiviral drugs for 2 weeks and 18% do not use any antivirals for HZO [16] .
In chronic and refractory cases, high amounts of VZV DNA were detected over a long period. If antivirals are discontinued after presumed clinical remission with significant viral replication, a recurrence in the form of delayed dendritic ulcer or iritis developing as ocular complications can be expected. In these settings, the diagnosis by qPCR for eye wash samples is sensitive enough to be effective. Its noninvasiveness allows repeated testing when necessary. Thus, VZV qPCR will be beneficial for clinicians to optimize drug Fig. 3 Association of duration of VZV keratitis to VZV DNA copy number and clinical characteristics. Disease duration was analyzed using Kaplan-Meier survival analysis and plotted on non-healing rate. a High VZV DNA copy number (≥ median (10 4 .19 copies); P = 0.008, log-rank test), the presence of iritis (P = 0.01), and b history of recurrences (P = 0.006) were significantly associated with the disease duration dosage and duration during the course of the disease process when the signs are resolving.
The presence of iritis was recently shown to be significantly associated with a risk of recurrences or chronicity in VZV keratitis after HZO [2] . We found that iritis with low copy numbers of VZV DNA was not a significant risk factor for refractoriness (Fig. 3a) . Instead, a combination of high amounts of VZV DNA copy numbers and iritis were the most significant factors in the refractory cases. In refractory or chronic cases, high VZV DNA copy numbers were maintained until the inflammation subsided. This suggests that prolonged viral replication and not the presence of iritis, determines the disease course in refractory cases.
The results of two studies suggest that the detection of VZV may be caused by shedding and is independent of refractoriness [8, 17] . In addition, VZV may often be reactivated in the saliva of healthy individuals when under extreme stress [17] . In bone marrow transplant patients, 19% have subclinical viremia without signs of HZO [3, 18] . This suggests that the detection of viral genome is common and may not reflect the presence of the disease. In the Japanese population, seropositivity reaches almost 100% in elderly subjects [19] . However, we found that the rate of unrelated VZV shedding from the eye was very low (0.2%) even in eyes stressed by non-VZV keratitis. This is in marked contrast to ocular HSV infection, in which spontaneous HSV shedding in tears is observed in one-third of healthy subjects [20] .
Recurrence of ocular complications after HZO is frequent. The percentage of eyes with recurrences ranges between 5 and 25% depending during the duration of the observation period [2, 21, 22] . The recurrence percentage in our study was 21.6% which is consistent with previous reports. Tran et al. report that a recurrence of keratitis after HZO was associated with uveitis and ocular hypertension [2] . However, we could not confirm any significant association between the recurrences and the clinical signs or the VZV DNA copy numbers. Instead, we found that the disease duration of single episodes was the only significant risk factor for recurrence. We suggest that the clinical signs are secondary to the long disease course which would directly explain the recurrences.
There are several limitations to our study. Our data were obtained at a tertiary referral institution, and selection or referral bias may have affected our outcomes. However, our data are based on 12 consecutive years of observation and should provide epidemiological evidence for Asians. In addition, the outcomes from a large series of VZV qPCR data from the eye have not been available.
In conclusion, qPCR for VZV revealed an unexpectedly long viral replication period and provided an effective measure to assess the viral load accurately during the course of the disease process. We propose that the management strategy of ocular complication after HZO would be significantly improved with the use of VZV qPCR.
